The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.
The Research Institute for Medicines Instituto de Investiga磯 do Medicamento (iMed.ULisboa) is a multidisciplinary R&D Unit in Life and Health Sciences, hosted at Faculdade de Farmᣩa, Universidade de Lisboa (FF/ULisboa).
Eisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration, BSi will provide validated targets to Eisai ...View all
Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges
09 December, 2014
ABRF joint meeting of Midwest and SE Chapters
09 October, 2014